Isolated macrodactyly (OMIM 155500) belongs to a heterogeneous group of overgrowth syndromes. It is a congenital anomaly resulting in enlargement of all tissues localized to the terminal portions of a limb and caused by somatic mutations in the phosphatidylinositol 3-kinase catalytic alpha (PIK3CA, OMIM 171834) gene. Here we report a Hungarian girl with macrodactyly and syndactyly. Genetic screening at hotspots in the PIK3CA gene identified a mosaic mutation (c.1624G>A, p.Glu542Lys) in the affected tissue, but not in the peripheral blood. To date, this somatic mutation has been reported in eight patients affected by different forms of segmental overgrowth syndromes. Detailed analysis of the Hungarian child and previously reported cases suggests high phenotypic diversity associated with the p.Glu542Lys somatic mutation. The identification of the mutation provides a novel therapeutic modality for the affected patients: those who carry somatic mutations in the PIK3CA gene are potential recipients of a novel "repurposing" approach of rapamycin treatment.
Introduction
Macrodactyly (OMIM 155500) refers to a rare congenital malformation occurring in approximately 1 in 100,000 live births and is characterized by an increase in the size of all the structures of the limbs, including soft tissues, bones, vessels, nerves and skin (1) . It typically affects the terminal portions of the limb within a "nerve territory" and the individual peripheral nerve is both enlarged and elongated (1) . Recently macrodactyly has been added to the growing list of overgrowth syndromes caused by somatic mutations of the phosphatidylinositol 3-kinase catalytic alpha (PIK3CA, OMIM 171834) gene (1) (2) (3) .
Further somatic overgrowth diseases associated with mosaic PIK3CA mutations include fibroadipose hyperplasia and non-classifiable conditions characterized by muscular, boney and fatty tissue overgrowth, congenital lipomatous overgrowth, vascular malformations, epidermal nevi and skeletal abnormalities (CLOVES) syndrome, hemihyperplasia multiple lipomatosis, and the brain overgrowth conditions megalencephaly capillary malformation and megalencephaly-polymicrogyria-hydrocephalus syndrome (MPPH) (2, (4) (5) (6) (7) (8) . The phenotypic heterogeneity in these syndromes is attributed to the location of the cells bearing the mutation and to the proportion of the affected cells in the patient's tissues (9).
Here we describe a 4-year-old Hungarian patient with isolated macrodactyly and syndactyly caused by the c.1624G>A, p.Glu542Lys somatic mutation of the PIK3CA gene.
We also provide detailed comparison of the clinical symptoms of the Hungarian patient with previously reported cases having the same p.Glu542Lys somatic PIK3CA mutation.
Clinical report
A 4-year-old Hungarian girl was referred to the Department of Medical Genetics (University of Szeged, Szeged, HUNGARY) with isolated macrodactyly on the third and 4 fourth fingers of the left hand (Fig. 1a) . X-ray imaging proved that the disease is characterized not only by the overgrowth of the soft tissues but also by the overgrowth of the bones of the affected fingers (Fig. 1b) . In addition to macrodactyly, syndactyly was associated with concrescence of the fingers and was constrained to the soft tissues of the affected fingers and not to the bones (Fig. 1a,b) . The macrodactyly and syndactyly of the left hand was present at birth and slowly progressed with the growth of the child. On examination, no vascular abnormality was present. There was no associated abnormality of the internal organs. Other body parts were symmetric and equally developed. The patient's parents were clinically unaffected, and they were not aware of any other family members with either macrodactyly or syndactyly (Fig. 1c ).
The performed genetic investigation was approved by the Internal Review Board of the University of Szeged. The study was conducted according to the Principles of the Declaration of Helsinki. After informed consent was obtained from the parents, peripheral blood sample and deep surgical excision of the affected left hand were taken in order to perform genetic analysis. Genomic DNA was isolated with the QIAamp DNA Mini Kit (QIAGEN, Hilden, Germany). Primer sequences were obtained from the UCSC Genome Browser. The coding regions and flanking introns of the PIK3CA gene were amplified and sequenced with a traditional capillary sequencer (ABI Prism 7000). Since traditional sequencing did not identify any putative causative variant of the PIK3CA gene, mutational hotspots were screened using an in-house PCR-based restriction fragment assay which has been previously described (10) (Cambridge, UK). Examining the region surrounding codon 542, a PCR product of 180 base pairs in length was amplified and digested with the XbaI restriction enzyme for 2 hours at 37°C. The resulting fragments were detected by fluorescent read-out using GeneMapper ® software with GeneScan LIZ 500 (Life Technologies Corporation) as the size standard. A mosaic mutation at codon 542 (c.1624G>A, p.Glu542Lys) was identified in the affected tissue with 4% mutation burden (Fig. 2a) . This mutation was not present in the genomic DNA sample isolated from the peripheral blood of the patient (Fig. 2b) . This genetic analysis confirmed that the development of macrodactyly and syndactyly of the third and fourth fingers of the left hand are the consequence of the mosaicism of the p.Glu542Lys mutation in the PIK3CA gene.
Discussion
The case reported in this study presented with macrodactyly and syndactyly of the patients with the same somatic mutation; both were affected by macrodactyly. However, one of the patients was also affected by true muscular hemihypertrophy, which was also attributed to the presence of the somatic p.Glu542Lys PIK3CA mutation. A subsequent study has also reported three further patients with facial infiltrating lipomatosis, which was attributed to the presence of the somatic p.Glu542Lys mutation (12) . These patients did not exhibit macrodactyly.
The high phenotypic diversity associated with the somatic p.Glu542Lys mutation might be explained by the different time points, in which the mutational events occurred during embryogenesis. Patients with CLOVES syndrome might have developed the same somatic p.Glu542Lys mutation earlier during the embryogenesis than the ones with regional overgrowth (macrodactyly or facial infiltrating lipomatosis).
Genetic analysis has a huge significance for these patients, as once the genetic cause is determined, pharmacological intervention could be considered as a therapeutic option. In the interim, there are no clinically approved therapies for this condition; however there is a theoretical possibility that small molecule inhibitors of the PI3K-AKT-mTOR signaling pathway could be effective therapies for these patients (13, 14) . Rapamycin (sirolimus)
indirectly targets PI3K and may also be useful in treating macrodactyly (13, 14) . In addition, rapamycin has been reported to be effective in isolated cases of allied conditions and may promote a breakthrough in the treatment of macrodactyly and overgrowth syndromes.
However, long-term safety data of this treatment in PIK3CA-related overgrowth is currently lacking and, thus, indicates the need for formal clinical trials to evaluate safety and efficacy.
In light of the current situation, detailed genetic investigation and publication of these isolated cases is essential. (b) In DNA extracted from the peripheral blood, the peak indicating the presence of the mutation was absent in the digested PCR product, indicating the mosaicism of the mutation. 
